Page 4 - Adpt News Today

Adaptive Biotechnologies (NASDAQ:ADPT – Get Rating) had its target price boosted by analysts at Piper Sandler from $14.00 to $15.00 in a note issued to investors on Monday, The Fly reports. Piper Sandler’s price objective suggests a potential upside of 134.38% from the stock’s current price. ADPT has been the subject of a number of […]

Adaptive Biotechnologies (NASDAQ:ADPT – Get Rating) posted its quarterly earnings results on Wednesday. The company reported ($0.40) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.34) by ($0.06), Briefing.com reports. Adaptive Biotechnologies had a negative return on equity of 39.82% and a negative net margin of 105.87%. The business had revenue […]

Adaptive Biotechnologies (NASDAQ:ADPT – Get Rating) released its earnings results on Wednesday. The company reported ($0.40) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.34) by ($0.06), Briefing.com reports. The firm had revenue of $37.65 million during the quarter, compared to analyst estimates of $36.81 million. Adaptive Biotechnologies had a negative return […]

The case against cutting healthcare spending

Adaptive Biotechnologies Co. (NASDAQ:ADPT – Get Rating) was the target of a large increase in short interest in March. As of March 31st, there was short interest totalling 6,120,000 shares, an increase of 14.8% from the March 15th total of 5,330,000 shares. Based on an average daily volume of 952,800 shares, the days-to-cover ratio is […]

Adaptive Biotechnologies (NASDAQ:ADPT – Get Rating) and Acorda Therapeutics (NASDAQ:ACOR – Get Rating) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their dividends, valuation, earnings, institutional ownership, risk, analyst recommendations and profitability. Analyst Ratings This is a breakdown of recent ratings […]

Adaptive Biotechnologies Co. (NASDAQ:ADPT – Get Rating) Director Michelle Renee Griffin sold 2,341 shares of the stock in a transaction on Monday, March 27th. The shares were sold at an average price of $8.49, for a total value of $19,875.09. Following the sale, the director now owns 20,627 shares in the company, valued at approximately […]

Adaptive Biotechnologies Co. (NASDAQ:ADPT – Get Rating) traded down 3.8% on Tuesday . The company traded as low as $8.34 and last traded at $8.39. 161,632 shares traded hands during trading, a decline of 83% from the average session volume of 959,535 shares. The stock had previously closed at $8.72. Analyst Upgrades and Downgrades Several […]

Adaptive Biotechnologies Co. (NASDAQ:ADPT – Get Rating) shares rose 5% during mid-day trading on Friday . The stock traded as high as $8.24 and last traded at $8.23. Approximately 500,643 shares traded hands during trading, a decline of 48% from the average daily volume of 965,161 shares. The stock had previously closed at $7.84. Analysts […]

WINTON GROUP Ltd lifted its position in Adaptive Biotechnologies Co. (NASDAQ:ADPT – Get Rating) by 29.6% in the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 24,476 shares of the company’s stock after acquiring an additional 5,597 shares during the quarter. WINTON […]